chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Was in and out of the hospital; His second shot is now more than 42 days after the first shot; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HOSPITALISATION (Was in and out of the hospital) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HOSPITALISATION (Was in and out of the hospital) (seriousness criterion hospitalization) and INCOMPLETE COURSE OF VACCINATION (His second shot is now more than 42 days after the first shot). At the time of the report, HOSPITALISATION (Was in and out of the hospital) outcome was unknown and INCOMPLETE COURSE OF VACCINATION (His second shot is now more than 42 days after the first shot) had resolved.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications provided. The patient was in the hospital and his second shot was now more than 42 days after the first shot. He was in and out of the hospital and this put his schedule off caller. No treatment information provided.  Company Comment:  Very limited information regarding this event of hospitalization has been provided at this time. Further information has been requested. Based on the current information available, temporal association between the use of the product and the start date of the event of hospitalization, a causal relationship cannot be excluded.; Sender's Comments: Very limited information regarding this event of hospitalization has been provided at this time. Further information has been requested. Based on the current information available, temporal association between the use of the product and the start date of the event of hospitalization, a causal relationship cannot be excluded.
Developed rash on leg, then edema to face and lips. Received 10 mg Benadryl by mouth.
Client returned to this clinic on 3-18-08.  Client presents with L. mid-upper deltoid with yellowish-purple bruised area approximately 10-15 mm.  Below bruised area, primary area approximately 4.5 inches diameter from medial to lateral aspect was red and inflamed.  (This does not extend to the underside of the arm.)  Secondary reddened area noted, (triceps area) below extending approximately 2.5 inches in diameter.  (See picture and additional documentation attached.)  Lower one third of arm (triceps area) is red and inflamed.  Rt Lower triceps area observed with pinhole needle mark by nurse.  No obvious reaction present at this site.  Client was extremely irritated and uncooperative due to previous discussions with other staff members in another clinical area.  This nurse was not able to converse with or complete an accurate physical assessment of the deltoid area.  The client and interpreter walked out of this clinic.  Nurse did inform both client and interpreter to seek follow up with their primary provider.  Nurse indicated that the deltoid area was firm and warm to touch.
reports she had the second pfizer vaccine on Jan. 8.  She did not have any reactions from the first dose.  Within 2 hours of having the booster she had a sore throat and HA.  Saturday she had the same symptoms.  Sunday = worse HA, fatigue like " i was hit by a truck" nausea and vomiting. Today, 1/11 she woke up with fever 101.3,  took Tylenol and ibuprofen and it went down;  dizzy and vomiting early this morning around 5am. Feeling slightly better now at 1130. However pending COVID results due to multitude of sx?s = may not be reaction to Booster, but rather actually COVID.
Received IM injection 12:30 PM. 4 hrs later swelling at site and up into her back, swelling to hard (R) very painful to touch. 24 hrs later pain less but very reddened arm feeling "itchy". Pt with sl nausea. Resolved after 24 hrs.
Inappropriate schedule of vaccine administered (1 Dose- 30Mar2021/ 2 Dose- 02Jun2021); rash on her abdomen, both side of sternum, which looked like hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (rash on her abdomen, both side of sternum, which looked like hives) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered (1 Dose- 30Mar2021/ 2 Dose- 02Jun2021)) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.    On 02-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Jun-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered (1 Dose- 30Mar2021/ 2 Dose- 02Jun2021)). On an unknown date, the patient experienced URTICARIA (rash on her abdomen, both side of sternum, which looked like hives). On 02-Jun-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered (1 Dose- 30Mar2021/ 2 Dose- 02Jun2021)) had resolved. At the time of the report, URTICARIA (rash on her abdomen, both side of sternum, which looked like hives) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medication was provided.   This case was linked to MOD-2021-403687, MOD-2021-404966 (Patient Link).
6/24/13 occurred 1 hour after injection. Pt. c/o redness, swelling, inability to move (R) arm, fever, chills, rash.
Suspected vaccination failure/Received the 2 Shingrex shots and still got shingles; Still got shingles/it was quite painful but about a month; It was quite painful; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles and pain were recovered/resolved.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingrix and Shingrix.     Additional Information: GSK receipt date: 30-Sept-2022 Reporter's comment: The case was received from the patient via interactive digital media. The patient received the 2 Shingrix shots and still got shingles this past spring. It was quite painful, but only lasted for about a month. The patient thought that it would have been worse if he/she had not gotten the shots. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available. As per the verbatim, 'It was quite painful, but only lasted for about a month', outcome and duration for shingles event was captured as recovered same as pain, considering that patient was explaining the shingles in brief.
Patient was given a 4th 0.25ml dose.  Patient had received a 0.25 ml booster dose in Nov 2021
102 fever for 2 days Nausea  Fatigue  Body aches Chills Chest tightness  Sore throat
Developed inflammation in L axilla, L breast, L upper arm.  Started on Medrol dose pack 10/11/2010.
Expired 3rd dose administered; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired 3rd dose administered) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired 3rd dose administered). On 27-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Expired 3rd dose administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2021-370951 (Patient Link).
Swelling and hives at injection site as well as whole arm swelling, all over joint pain, back pain, fever, fatigue and chills- severe headaches. Biggest issue- Migraines that have not stopped since the injections- note* I?ve never had a migraine in my entire life.
Patient felt dizzy and had syncope, fell back and hit head in occipital area and had seizure like activity in (R) upper side of arm for 30 sec. Patient was laid in floor and then responded and was transferred to a room. Vitals were taken and were stable. Accucheck-90 B/P-123/76.
Information has been received from a physician, for Pregnancy Registry for GARDASIL, concerning a 15 year old female with a history of 0 pregnancies and 0 live births and no other medical history or drug allergies who on 08-OCT-2006 was vaccinated intramuscularly with the first 0.5 ml dose of GARDASIL in the deltoid and on 10-AUG-2007, was vaccinated intramuscularly with the second 0.5 ml dose of GARDASIL in the deltoid (lot # 654510/0962F).  Concomitant therapy included minocycline.  The patient delivered a healthy baby on 27-FEB-2008.  Weight: 6 pounds 14 ounces, Length: 50.0cm, Apgar score: 9/9, Head circumference: 20 inches.  No adverse symptoms.  Medical attention was sought via office visit.  No product quality complaint was involved.  There were no congenital anomalies or other complication or abnormalities.  Pediatric medical records were received and reviewed and the following experiences were identified: A 06-MAR-2008 office visit noted that the male child had eye discharge and required special formula due to lactose intolerance.  The healthy male, was born on 27-FEB-2008 via normal spontaneous vaginal delivery.  On 27-FEB-2008, poly vitamin with fluoride with Iron multiple vitamins with Iron and Fluoride 0.25 50, 1 dropperful, PO, once a day and erythromycin ophthalmic ointment 0.5%, QID, were prescribed.  On 15-MAY-2008 the male child was vaccinated with PEDIARIX, PNEUMOVAX, ROTATEQ (manufacturer unknown) and HIB (manufacturer unknown).  On 25-AUG-2008 the child was vaccinated with PEDIARIX, PNEUMOVAX (manufacturer unknown) and HIB (manufacturer unknown).  Additional information is not expected.
Diagnosed with Breast Cancer - Type: Triple Negative - Stage 3C - large tumor measures 7 cm in August 2022 by biopsy after physical breast exam by doctor in July 2022. History of dense breast tissue so cancer was undetected in mammograms in May 2022 and July 2021. NO CANCER detected in ultrasound in December 2021 just 3 months before vaccine. Treatment Plan - 6 months of chemotherapy then mastectomy and radiation (just started chemotherapy). NO FAMILY HISTORY OF BREAST CANCER. Due to the size of the largest tumor and statistical data about how Triple Negative tumors grow, the date of the vaccine corresponds with the origin of the tumor. I have never tested positive for COVID.
Feeling bad; Diarrhea; upset stomach; Back pain; sick/doesnt know if she has a bug or if she ate something bad; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feeling bad), DIARRHOEA (Diarrhea), ABDOMINAL DISCOMFORT (upset stomach), BACK PAIN (Back pain) and ILLNESS (sick/doesnt know if she has a bug or if she ate something bad) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced FEELING ABNORMAL (Feeling bad), DIARRHOEA (Diarrhea), ABDOMINAL DISCOMFORT (upset stomach), BACK PAIN (Back pain) and ILLNESS (sick/doesnt know if she has a bug or if she ate something bad). At the time of the report, FEELING ABNORMAL (Feeling bad), DIARRHOEA (Diarrhea), ABDOMINAL DISCOMFORT (upset stomach), BACK PAIN (Back pain) and ILLNESS (sick/doesnt know if she has a bug or if she ate something bad) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.  No treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 19-May-2021: Additional information received on 19-May-2021. Patient informed that he did not experience any of the mentioned events.
Initial case received from a health care professional on 19 July 2011. A 45-year-old male patient received dose 3 of IMOVAX Rabies, sanofi pasteur SA lot number not reported, on 08 July 2011. The patient had a history of allergy to artificial strawberries. He had been ill since February with multiple problems including prostatitis and tonsillitis. The patient has been in bed most of June but felt better when started the vaccines. His concomitant medications were not reported. The patient had a dog bite on 28 June 2011. The patient received dose 1 of IMOVAX Rabies on 29 June 2011, dose 2 on 04 July 2011 and dose 3 on 08 July 2011. The patient developed the feeling of a little fatigued after the first three doses. He complained of feeling very weak and feels he had an increased sensitivity to noises and light. The outcome was reported as not recovered. Follow-up information was received from a health care professional on 26 August 2011. The patient had only received one dose of the rabies vaccine at the hospital and the lot number was not recorded. It was discovered that the patient had been the initial reporter which was previously reported as a health care professional. No further information was available. The outcome remained not recovered. Follow-up information was received 01 September 2011 from a health care professional. According to the reporter, the patient had only received a first dose of IMOVAX Rabies vaccine (intramuscular left deltoid injection) on 01 July 2011 (previously reported as 29 June 2011) at their facility and that lot number had not been charted by the nurse. Outcome remained not recovered. Follow-up information received on 17 October 2011 from a health care professional. Per the reporter, only the first dose of IMOVAX Rabies was administered at the facility. The lot number was not documented. No information was provided regarding the patient's recovery status. The event after the first three doses of IMOVAX Rabies was captured in case 2011-05016. Documents held by sender: None.
2 days after booster, I had a significant spike in heart rate for 2 hours. My fitbit stated my heart was over 135 bpm for almost 2 hours and I also had a pulsing headache and sweating.
The 64 year-old patient received Fluzone HD which is indicated for patients 65 years and older. We were unsuccessful in contacting the patient as her voicemail box is full.
8-10 hrs p/ immun, episode of "not breathing", dx as choking episode in ER; MD feels was probably a sz, by maternal description, since then has had sz disorder; on Phenobarbital.
chills; fatigue; joint pain; headaches; This is a spontaneous report from a contactable consumer or other non-health care professional received from Pfizer-sponsored program.    A female patient of an unspecified age received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: unknown), dose 1, single via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced chills, fatigue, joint pain (arthralgia) and headaches on an unspecified date. The caller called on behalf of her mother asking if she could take any medications for her symptoms or that would affect the vaccine. At the time of reporting, the outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
(L) arm developed redness, swelling, tenderness, pain, 4" rash.
Awoke with mildly pruritic urticarial lesions at site of injection, face, neck, forearm, abd. Resolved after taking her Rxd meds listed below.
Symptoms consistent with Covid arm except it lasted approximately 3 weeks. It began at injection site down my arm to wrist. It was inflamed with fever and severe discomfort, blotches all over.  No one at CDC nor DOH would answer questions advise or other wise.  Extreme panic ensued and I was advised to go to an ER. COVID was everywhere.  No one to ease my panic.  I have pics.
Fever: None; Location: Left; Onset: 3 -7 days; Duration: Acute; Severity: Moderate; Quality: Worsening. L. arm swelling and redness has moved. Received flu shot 11/18/17. Reaction was noted the following day. Child has had a flu shot every year and never had a reaction. Mom noted the arm was getting swollen yesterday and was red, starting a finger's width below where the shot was given. Patient had a normal day yesterday and today. Moved his arms normally and no complaints of pain. He reports itching. Mom gave him BENADRYL and ibuprofen before bed and he slept fine last night. Today mom thinks the redness has improved, swelling seems the same. Plan: I'm not worried at this point about a compartment syndrome-type reaction, as he has full ROM and no pain. Since mom thinks redness has improved, I hope we're trending toward improvement. Mom is comfortable watching, but knows to have a low threshold to seek care urgently if swelling increases or child is complaining of pain. Ibuprofen and BENADRYL is fine before bed.
It started with chills and then I had a temperature that was as high as 100.6 degrees.  The temperature lasted for at least 6 hours.  I took off work the next day .
full body rash. pustular. painful on  palms and soles of feet used telemedicine dr who prescribed 0 meds. told me to ride it out  10/2- onset of L finger severe swelling, fever and pain.  onset random, no precipitating event. used telemedicine again and dr adivsed me to be seen in urgent care. Was seen in urgent care and told to take Allegra 60mg BID  other fingers starting to now hurt mildly as well
10/26/2021 I had the usual two day tired and achy all over, and that subsided within a couple of days. Then on 11/14/2021 I decided to see my doctor due to symptoms of GI and chest pains, and it has subsided I am being really careful with my diet. I am due to have a GI scan on 12/07/2021.
expired dose of Shingrix was administered to a patient; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a adult female patient who received Herpes zoster (Shingrix) (batch number 2JA2N, expiry date 06-OCT-2023) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced expired vaccine used (Verbatim: expired dose of Shingrix was administered to a patient). The outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt Date: 10-NOV-2023 The reporter stated that an expired dose of Shingrix was administered to a patient, which led to expired vaccine used. The Vaccine Administration Facility was the same as Primary Reporter. The reporter consented to follow up via postal.
On May 16 I had a sudden drop in heart rate. I was sitting and suddenly felt like all the energy was draining out of my body like an elevator. I checked my heart rate using my Fitbit. On May 17 I had atrial fibrillation all day. I contacted my doctor on May 17 and they scheduled me to come in. On Friday May 20, the doctor placed me in a heart halter monitor and completed blood work. Inflammation and insulin were both high in blood panel. I have been feeling ok daily. The atrial fibrillation did not reoccur. I am uncertain whether you recovered as your still waiting on results.
Underage before the 5/12 approval for Pfizer vaccine  Guardian elected to falsify DOB
Child was standing with stepmother at the front counter of the health department. They were paying for the vaccines and it had only been a few minutes since he had received the 3 injections. Child lost consciousness and hit head against wall. For about 5 seconds he appeared to have seizure like activity and was posturing. He was very pale. Cold cloth placed on his face. Child took deep breaths and slowly sat up after about 5 minutes of laying on the ground and deep breathing. Color slowly came back to his face and he drank some water. 911 had been called and EMTs came shortly after the event. Child said his head hurt from the fall but was getting better. EMTs took him to Hospital for further evaluation. Step mother followed behind ambulance in private vehicle.
fatigue/tiredness; chills; soreness at the site of the injection after 2nd dose of Moderna Covid-19 vaccination; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue/tiredness), CHILLS (chills) and VACCINATION SITE PAIN (soreness at the site of the injection after 2nd dose of Moderna Covid-19 vaccination) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. C03C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-May-2021, the patient experienced FATIGUE (fatigue/tiredness). 28-May-2021, the patient experienced CHILLS (chills) and VACCINATION SITE PAIN (soreness at the site of the injection after 2nd dose of Moderna Covid-19 vaccination). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 500 mg. At the time of the report, FATIGUE (fatigue/tiredness), CHILLS (chills) and VACCINATION SITE PAIN (soreness at the site of the injection after 2nd dose of Moderna Covid-19 vaccination) outcome was unknown.            No concomitant medications were provided.   This case was linked to MOD-2021-100454, MOD-2021-100454 (Patient Link).
Patient developed rash on left arm 7 days after receiving the vaccine. Rash described as erythematous with multiple papules, with itching and discomfort. The rash subsided 4 days later.
I went to the pharmacy for a flu shot on Saturday,  December 22. I felt fine that day, but by Sunday afternoon, had a mild fever and was very tired. Some online research convinced me these were normal side effects to the shot, so I wasn't overly concerned. However, by Monday (Christmas Eve), I was coughing excessively. On Christmas Day,  I had a fever in excess of 103°, and could not get out of bed all day. I went to the doctor on December 26, and was given a flu test,  and diagnosed with the flu. I realize that it is supposed to be impossible to get the flu from the vaccination, however I felt completely fine prior to the shot, and am the only one in my home that came down with the flu. It just seemed too coincidental to not report it.
A few minutes after received Pfizer covid-19 vaccine, patient got syncope in chair ( her cell phone, bottle of drink and hand bag were dropped on floor); she got anxious and kept calling for " help". After she drank some water and got recovery shortly. EMS arrived and evaluated her condition. Later patient could walk out with her friend.
Cold, clammy to the touch, feeling faint.  B/P 105/78, HR 69, O2Sat 98%.